The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Tipster. What is the writing on the wall in your view?
Is your view that 510K clearance will not be achieved? All available commentary (to the best of my knowledge) is pointing towards eventual clearance (all be it there has been a delays in what is an understandably complex clearance process) , so wondered what your view is and what it is based on?
What significance is the level of activity on this BB board in your view? It has zero impact on the fundamentals of TEK.
Best of luck with your investment choices, whether you stay in with TEK or invest elsewhere.
You’re lucky walking away with 30%. Wish I was breaking even, I’d walk. Too far gone. Writing was on the wall with the **** up with Belleuscura. Serious investors probably got spooked. BB board is like the Marie-Celeste. Tempted to sell at 35% loss and pump into Odx , Sng or such like.
Not much more patience required they have provided indicative dates for updates on Guident and we should get news on Salarius albeit not what we want to hear apart from a few bags of crisps being sold. FDA news has to drop in the next 4/6 weeks if there is any truth in what they said about everything being submitted for approval. I'm giving them 6 weeks to come good and if it's just same old tosh then I'm out. If the SP continues to be stuck here at least I'll walk with 30% extra money. I do feel for those that bought in much higher on all the promises but who knows they could still nail something.
Just a little more patience and we will all be handsomely rewarded.
How long before Cliff starts rattling the tin again ? Tek's ip companies never bring any money in but it's easy for TEK to keep inflating the NAV. It's always jam tomorrow with this lot.
Johnjojim I wouldn't hold your breath mate on FDA, we have to remember this lot buy ideas with our money then so far have really struggled to make money from them. When I say make money I mean a profit.
You can have all the patents you want but unless you can sell I really can't see the point. Be like a patent for a chocolate fire guard :)
8mo they've got more chance of selling Guident to Tesla than getting any more money out of me. Nice to see news flow has improved and the SP has bottomed out and steady. FDA can't be far away now that everything has been submitted that's required by the FDA, I'll presume the extra units have been done but it would be nice to have confirmation on that.
Steve, thanks for sharing. It seems to me that the reason the CEO was copied into the reply is because he is after your money! Tell him to get the share price going first before you part with any more cash.
As of 30th July I received an update after making some further inquiries into how Salarius sales were progressing and if it was possible to purchase any products currently using the salt product. I received the following by reply.
"Good afternoon Steve, MicroSalt is an emerging ingredient product and the only current brand using the product is SaltMe! potato chips (www.saltme.com) which is owned by Salarius and is our proof of concept. You can order the chips online on the website. The brand is in distribution through United Natural Foods and we launched in May and are in about 70 stores in the NE/Mid Atlantic region and growing. The product has been tested on nuts, popcorn, in spice mixes and other products but none have come to market yet.
You will not find MicroSalt itself as a product yet, like the other products you shared, as we are in development of how to come to market with the MicroSalt itself rather than using it as an ingredient in other products like salty snacks. Sell sheet is attached
We are currently looking in a fund raise so if you are interested, I am copying our CEO on this email and he can provide you with additional details and get you set up with a product sample."
The reply to my enquiry was also copied into the CEO of Salarius. Looks like these guys are really taking things seriously especially when a CEO gets copied in on a reply.
Looks like we should be getting some news shortly on crisp sales figures that should give the SP a boost.